High-Risk Human Papillomavirus (Hpv) Infection in Women Undergoing in Vitro Fertilization / Okužbe Z Visokorizičnimi Genotipi Humanih Papilomskih Virusov (Hpv) Pri Ženskah, Vključenih V Postopke Zunajtelesne Oploditve

1. Bouvard V, Baan R, Straif K, Grosse Y, Secretan B, El Ghissassi F et al. A review of human carcinogens - Part B: biological agents. Lancet Oncol 2009; 10: 321-322.10.1016/S1470-2045(09)70096-8Search in Google Scholar

2. Jancar N, Kocjan BJ, Poljak M, Lunar MM, Bokal EV. Distribution of human papillomavirus genotypes in women with cervical cancer in Slovenia. Eur J Obstet Gynecol Reprod Biol 2009; 145: 184-188.10.1016/j.ejogrb.2009.04.030Search in Google Scholar

3. Lytwyn A, Sellors JW, Mahony JB, Daya D, Chapman W, Howard M, et al. Adjunctive human papillomavirus testing in the 2-year followup of women with low-grade cervical cytologic abnormalities. Arch Pathol Lab Med 2003; 127: 1169-1175.10.5858/2003-127-1169-AHPTITSearch in Google Scholar

4. Arbyn M, Paraskevaidis E, Martin-Hirsch P, Prendiville W, Dillner J. Clinical utility of HPV-DNA detection: triage of minor cervical lesions, follow-up of women treated for high-grade CIN: an update of pooled evidence. Gynecol Oncol 2005; 99: S7-S11.10.1016/j.ygyno.2005.07.033Search in Google Scholar

5. Wright TC Jr, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D. 2006 American Society for Colposcopy and Cervical Pathology-sponsored Consensus Conference. 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am J Obstet Gynecol 2007; 197: 346-355.10.1016/j.ajog.2007.07.047Search in Google Scholar

6. Arbyn M, Anttila A, Jordan J, Ronco G, Schenck U, Segnan N, et al. European guidelines for cervical quality assurance in cervical cancer screening: summary document. 2nd ed. Ann Oncol 2010; 21: 448-458.10.1093/annonc/mdp471Search in Google Scholar

7. Cox JT. History of the use of HPV testing in cervical screening and in the management of abnormal cervical screening results. J Clin Virol 2009; 45: S3-S12.10.1016/S1386-6532(09)70002-2Search in Google Scholar

8. Uršič-Vrščaj M, Rakar S, Možina A, Kobal B, Takač I, Deisinger D, et al. Smernice za celostno obravnavo žensk s predrakavimi spremembami materničnega vratu. Ljubljana: Onkološki inštitut, 2011.Search in Google Scholar

9. Pellati D, Mylonakis I, Bertoloni G, Fiore C, Andrisani A, Ambrosini G, et al. Genital tract infections and infertility. Eur J Obstet Gynecol Reprod Biol 2008; 140: 3-11.10.1016/j.ejogrb.2008.03.00918456385Search in Google Scholar

10. Ochsendorf FR. Sexually transmitted infections: impact on male fertility. Andrologia 2008; 40: 72-75.10.1111/j.1439-0272.2007.00825.x18336453Search in Google Scholar

11. Lundqvist M, Westin C, Lundkvist Ö, Simberg N, Strand A, Andersson S, et al. Cytologic screening and human papillomavirus test in women undergoing artificial fertilization. Acta Obstet Gynecol Scand 2002; 81: 949-953.10.1034/j.1600-0412.2002.811009.x12366486Search in Google Scholar

12. Wang Y, Wang C, Qiao J, Wang L, Liang S. Relationship of cytopathology and cervical infection to outcome of in-vitro fertilization embryo transfer. Int J Gynecol Obstet 2008; 101: 21-26.10.1016/j.ijgo.2007.09.035Search in Google Scholar

13. Tanaka H, Karube A, Kodama H, Fukuda J, Tanaka T. Mass screening for human papillomavirus type 16 infection in infertile couples. J Reprod Med 2000; 45: 907-911.Search in Google Scholar

14. Spandorfer SD, Bongiovanni AM, Fasioulotis S, Rosenwaks Z, Ledger WJ, Witkin SS. Prevalence o cervical human papillomavirus in women undergoing in vitro fertilization and association with outcome. Fertil Steril 2006; 86: 765-767.10.1016/j.fertnstert.2006.01.051Search in Google Scholar

15. Almonte M, Silva Idos S, Asare A, Gilham C, Sargent A, Bailey A, et al. Sexual behavior and HPV infection in British women, by postal questionnaires and telephone interviews. J Med Virol 2011; 83: 1238-1246.10.1002/jmv.22085Search in Google Scholar

16. Huang S, Tang N, Mak WB, Erickson B, Salituro J, Li Y, et al. Principles and analytical performance of Abbott RealTime HR HPV test. J Clin Virol 2009; 45: S13-S17.10.1016/S1386-6532(09)70003-4Search in Google Scholar

17. Poljak M, Ostrbenk A, Seme K, Ucakar V, Hillemanns P, Bokal EV, et al. Comparison of clinical and analytical performance of the Abbott Realtime High Risk HPV test to the performance of hybrid capture 2 in population-based cervical cancer screening. J Clin Microbiol 2011; 49: 1721-1729.10.1128/JCM.00012-11312264121430098Search in Google Scholar

18. De Vuyst H, Clifford G, Li N, Franceschi S. HPV infection in Europe. Eur J Cancer 2009; 45: 2632-2639.10.1016/j.ejca.2009.07.01919709878Search in Google Scholar

19. Učakar V, Poljak M, Klavs I. Pre-vaccination prevalence and distribution of high-risk human papillomavirus (HPV) types in Slovenian women: a cervical cancer screening based study. Vaccine 2012; 30: 116-120.10.1016/j.vaccine.2011.10.06622080175Search in Google Scholar